arrow
N

Naoise C. Synnott

national institutes of health (nih) - usa
H指数:15
被引数:1,887

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial

Synnott, N.C.; Polymeropoulos, C.M.; Xiao, C.; Birznieks, G.; Polymeropoulos, M.H. 褪黑素受体激动剂tasimelteon(HETLIOZ®)改善原发性失眠患者的睡眠:一项多中心、随机、双盲、安慰剂对照试验。PLoS ONE 2025, 20, e0332366. [Google Scholar] [CrossRef]

2025-09-190
OA
Characterizing the tumor microenvironment in rare renal cancer histological types

罕见肾癌组织学类型的肿瘤微环境特征

2021-10-0711
OAAI
Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-Smokers

通过突变特征追踪从不吸烟者的肺癌危险因素

2020-10-2823
OAAI